How digital health companies can leverage unstructured data in clinical evidence

As competition in the digital health space intensifies and failures become more common, earning regulatory approval and clinical acceptance of new products is more important than ever. Digital clinical trials can show regulators and clinicians how a digital health product can improve the lives of patients, and these trials need access to high-quality, real-world data (RWD).

Thankfully for digital health companies, they’re not starting from scratch. Many have unstructured data assets they’ve created or acquired that they can use to develop useful RWD. When considering the state of your unstructured data, it’s important to consider four variables.

Click Me